Purchases and Sales Made in Q3 2024 in Enlivex Therapeutics Ltd. (ENLV)
This table provides information about the institutional ownership of Enlivex Therapeutics Ltd. (ENLV) during Q3 2024. The information is specifically focused on institutions that hold shares of Enlivex Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
438K+ 25.78% |
$526K - $741K
|
2.14M
$2.67M
|
|
|
Oct 23, 2024
Q3 2024
|
Sigma Investment Counselors Inc
|
BUY
|
- |
30KNew |
$36K - $50.7K
|
30K
$37.5K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
BUY
|
- |
3.2K+ 20006.25% |
$3.84K - $5.41K
|
3.22K
$4.02K
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
3.1K+ 4.32% |
$3.72K - $5.24K
|
74.8K
$93.5K
|
|
|
Oct 21, 2024
Q3 2024
|
Signaturefd, LLC
Atlanta, GA |
BUY
|
- |
3KNew |
$3.6K - $5.07K
|
3K
$3.75K
|
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
2.51K+ 21.93% |
$3.01K - $4.24K
|
13.9K
$17.4K
|
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
1.58K+ 685.28% |
$1.9K - $2.68K
|
1.81K
$2.27K
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
862+ 0.35% |
$1.03K - $1.46K
|
246K
$307K
|
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
145New |
$174 - $245
|
145
$181
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2024
Q3 2024
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-19- 0.33% |
$22.8 - $32.1
|
5.73K
$7.16K
|
|
|
Nov 14, 2024
Q3 2024
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-2.16K- 8.71% |
$2.59K - $3.65K
|
22.7K
$28.3K
|